CD4 and neoplasm: The combination of α-PD-1 and α-CTLA-4 can suppress tumor development by T cell infiltration into tumors and the induction of polyfunctional effector tumor infiltrating lymphocytes (TIL), probably CD4+ and CD8+ T cells [23].